10-Q 1 fmc-20240930.htm 10-Q fmc-20240930
000003778512/312024Q3FALSEhttp://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense368xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesfmc:productxbrli:pureutr:MMBTU00000377852024-01-012024-09-3000000377852024-09-3000000377852024-07-012024-09-3000000377852023-07-012023-09-3000000377852023-01-012023-09-3000000377852023-12-310000037785fmc:FuradanProductExitMember2024-09-300000037785fmc:FuradanProductExitMember2023-09-3000000377852022-12-3100000377852023-09-300000037785us-gaap:CommonStockMember2023-12-310000037785us-gaap:AdditionalPaidInCapitalMember2023-12-310000037785us-gaap:RetainedEarningsMember2023-12-310000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000037785us-gaap:TreasuryStockCommonMember2023-12-310000037785us-gaap:NoncontrollingInterestMember2023-12-310000037785us-gaap:RetainedEarningsMember2024-01-012024-03-310000037785us-gaap:NoncontrollingInterestMember2024-01-012024-03-3100000377852024-01-012024-03-310000037785us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000037785us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000037785us-gaap:CommonStockMember2024-03-310000037785us-gaap:AdditionalPaidInCapitalMember2024-03-310000037785us-gaap:RetainedEarningsMember2024-03-310000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000037785us-gaap:TreasuryStockCommonMember2024-03-310000037785us-gaap:NoncontrollingInterestMember2024-03-3100000377852024-03-310000037785us-gaap:RetainedEarningsMember2024-04-012024-06-300000037785us-gaap:NoncontrollingInterestMember2024-04-012024-06-3000000377852024-04-012024-06-300000037785us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300000037785us-gaap:CommonStockMember2024-06-300000037785us-gaap:AdditionalPaidInCapitalMember2024-06-300000037785us-gaap:RetainedEarningsMember2024-06-300000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000037785us-gaap:TreasuryStockCommonMember2024-06-300000037785us-gaap:NoncontrollingInterestMember2024-06-3000000377852024-06-300000037785us-gaap:RetainedEarningsMember2024-07-012024-09-300000037785us-gaap:NoncontrollingInterestMember2024-07-012024-09-300000037785us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300000037785us-gaap:TreasuryStockCommonMember2024-07-012024-09-300000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000037785us-gaap:CommonStockMember2024-09-300000037785us-gaap:AdditionalPaidInCapitalMember2024-09-300000037785us-gaap:RetainedEarningsMember2024-09-300000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300000037785us-gaap:TreasuryStockCommonMember2024-09-300000037785us-gaap:NoncontrollingInterestMember2024-09-300000037785us-gaap:CommonStockMember2022-12-310000037785us-gaap:AdditionalPaidInCapitalMember2022-12-310000037785us-gaap:RetainedEarningsMember2022-12-310000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000037785us-gaap:TreasuryStockCommonMember2022-12-310000037785us-gaap:NoncontrollingInterestMember2022-12-310000037785us-gaap:RetainedEarningsMember2023-01-012023-03-310000037785us-gaap:NoncontrollingInterestMember2023-01-012023-03-3100000377852023-01-012023-03-310000037785us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000037785us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000037785us-gaap:CommonStockMember2023-03-310000037785us-gaap:AdditionalPaidInCapitalMember2023-03-310000037785us-gaap:RetainedEarningsMember2023-03-310000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000037785us-gaap:TreasuryStockCommonMember2023-03-310000037785us-gaap:NoncontrollingInterestMember2023-03-3100000377852023-03-310000037785us-gaap:RetainedEarningsMember2023-04-012023-06-300000037785us-gaap:NoncontrollingInterestMember2023-04-012023-06-3000000377852023-04-012023-06-300000037785us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000037785us-gaap:TreasuryStockCommonMember2023-04-012023-06-300000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300000037785us-gaap:CommonStockMember2023-06-300000037785us-gaap:AdditionalPaidInCapitalMember2023-06-300000037785us-gaap:RetainedEarningsMember2023-06-300000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000037785us-gaap:TreasuryStockCommonMember2023-06-300000037785us-gaap:NoncontrollingInterestMember2023-06-3000000377852023-06-300000037785us-gaap:RetainedEarningsMember2023-07-012023-09-300000037785us-gaap:NoncontrollingInterestMember2023-07-012023-09-300000037785us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300000037785us-gaap:TreasuryStockCommonMember2023-07-012023-09-300000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000037785us-gaap:CommonStockMember2023-09-300000037785us-gaap:AdditionalPaidInCapitalMember2023-09-300000037785us-gaap:RetainedEarningsMember2023-09-300000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300000037785us-gaap:TreasuryStockCommonMember2023-09-300000037785us-gaap:NoncontrollingInterestMember2023-09-300000037785us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberfmc:GlobalSpecialtyMember2024-07-110000037785us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberfmc:GlobalSpecialtyMember2024-09-300000037785srt:NorthAmericaMember2024-07-012024-09-300000037785srt:NorthAmericaMember2023-07-012023-09-300000037785srt:NorthAmericaMember2024-01-012024-09-300000037785srt:NorthAmericaMember2023-01-012023-09-300000037785srt:LatinAmericaMember2024-07-012024-09-300000037785srt:LatinAmericaMember2023-07-012023-09-300000037785srt:LatinAmericaMember2024-01-012024-09-300000037785srt:LatinAmericaMember2023-01-012023-09-300000037785us-gaap:EMEAMember2024-07-012024-09-300000037785us-gaap:EMEAMember2023-07-012023-09-300000037785us-gaap:EMEAMember2024-01-012024-09-300000037785us-gaap:EMEAMember2023-01-012023-09-300000037785srt:AsiaMember2024-07-012024-09-300000037785srt:AsiaMember2023-07-012023-09-300000037785srt:AsiaMember2024-01-012024-09-300000037785srt:AsiaMember2023-01-012023-09-300000037785fmc:InsecticidesMember2024-07-012024-09-300000037785fmc:InsecticidesMember2023-07-012023-09-300000037785fmc:InsecticidesMember2024-01-012024-09-300000037785fmc:InsecticidesMember2023-01-012023-09-300000037785fmc:HerbicidesMember2024-07-012024-09-300000037785fmc:HerbicidesMember2023-07-012023-09-300000037785fmc:HerbicidesMember2024-01-012024-09-300000037785fmc:HerbicidesMember2023-01-012023-09-300000037785fmc:FungicidesMember2024-07-012024-09-300000037785fmc:FungicidesMember2023-07-012023-09-300000037785fmc:FungicidesMember2024-01-012024-09-300000037785fmc:FungicidesMember2023-01-012023-09-300000037785fmc:PlantHealthMember2024-07-012024-09-300000037785fmc:PlantHealthMember2023-07-012023-09-300000037785fmc:PlantHealthMember2024-01-012024-09-300000037785fmc:PlantHealthMember2023-01-012023-09-300000037785us-gaap:ProductAndServiceOtherMember2024-07-012024-09-300000037785us-gaap:ProductAndServiceOtherMember2023-07-012023-09-300000037785us-gaap:ProductAndServiceOtherMember2024-01-012024-09-300000037785us-gaap:ProductAndServiceOtherMember2023-01-012023-09-300000037785us-gaap:CustomerRelationshipsMember2024-09-300000037785us-gaap:CustomerRelationshipsMember2023-12-310000037785us-gaap:PatentsMember2024-09-300000037785us-gaap:PatentsMember2023-12-310000037785fmc:BrandsMember2024-09-300000037785fmc:BrandsMember2023-12-310000037785us-gaap:DevelopedTechnologyRightsMember2024-09-300000037785us-gaap:DevelopedTechnologyRightsMember2023-12-310000037785us-gaap:OtherIntangibleAssetsMember2024-09-300000037785us-gaap:OtherIntangibleAssetsMember2023-12-310000037785fmc:CropProtectionBrandsMember2024-09-300000037785fmc:CropProtectionBrandsMember2023-12-310000037785fmc:BrandsMember2024-09-300000037785fmc:BrandsMember2023-12-310000037785us-gaap:InProcessResearchAndDevelopmentMember2024-09-300000037785us-gaap:InProcessResearchAndDevelopmentMember2023-12-3100000377852023-01-012023-12-310000037785fmc:ReceivablesSecuritizationFacilityMember2024-01-012024-09-300000037785fmc:ReceivablesSecuritizationFacilityMember2023-01-012023-09-300000037785fmc:ProjectFocusMember2024-07-012024-09-300000037785fmc:OtherRestructuringActivitiesMember2024-07-012024-09-300000037785fmc:OtherRestructuringActivitiesMember2023-07-012023-09-300000037785fmc:ProjectFocusMember2024-01-012024-09-300000037785fmc:OtherRestructuringActivitiesMember2024-01-012024-09-300000037785fmc:DuPontCropRestructuringMember2023-01-012023-09-300000037785fmc:OtherRestructuringActivitiesMember2023-01-012023-09-300000037785us-gaap:FacilityClosingMember2024-07-012024-09-300000037785us-gaap:FacilityClosingMember2024-01-012024-09-300000037785fmc:ProfessionalServiceProviderCostsMemberfmc:ProjectFocusMember2024-01-012024-09-300000037785us-gaap:OtherRestructuringMemberfmc:ProjectFocusMember2024-01-012024-09-300000037785fmc:ProjectFocusMember2023-12-310000037785fmc:ProjectFocusMember2024-09-300000037785fmc:DuPontCropRestructuringMember2023-12-310000037785fmc:DuPontCropRestructuringMember2024-01-012024-09-300000037785fmc:DuPontCropRestructuringMember2024-09-300000037785fmc:OtherWorkforceRelatedAndFacilityShutdownsMember2023-12-310000037785fmc:OtherWorkforceRelatedAndFacilityShutdownsMember2024-01-012024-09-300000037785fmc:OtherWorkforceRelatedAndFacilityShutdownsMember2024-09-300000037785fmc:ShorttermForeignDebtMember2024-09-300000037785fmc:ShorttermForeignDebtMember2023-12-310000037785us-gaap:CommercialPaperMember2024-09-300000037785us-gaap:CommercialPaperMember2023-12-310000037785us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-300000037785fmc:PollutionControlAndIndustrialRevenueBondsMember2024-09-300000037785fmc:PollutionControlAndIndustrialRevenueBondsMember2023-12-310000037785us-gaap:SeniorNotesMember2024-09-300000037785us-gaap:SeniorNotesMember2023-12-310000037785us-gaap:SeniorNotesMembersrt:MinimumMember2024-09-300000037785us-gaap:SeniorNotesMembersrt:MaximumMember2024-09-300000037785us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-300000037785us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-12-310000037785fmc:ForeignDebtMembersrt:MinimumMember2024-09-300000037785fmc:ForeignDebtMembersrt:MaximumMember2024-09-300000037785fmc:ForeignDebtMember2024-09-300000037785fmc:ForeignDebtMember2023-12-310000037785us-gaap:RevolvingCreditFacilityMember2024-09-300000037785fmc:RevolvingCreditFacilityAndTermLoanFacility2017Memberus-gaap:LineOfCreditMember2024-01-012024-09-300000037785fmc:DiscontinuedworkerscompensationproductliabilityandotherpostretirementbenefitsMember2024-07-012024-09-300000037785fmc:DiscontinuedworkerscompensationproductliabilityandotherpostretirementbenefitsMember2023-07-012023-09-300000037785fmc:DiscontinuedworkerscompensationproductliabilityandotherpostretirementbenefitsMember2024-01-012024-09-300000037785fmc:DiscontinuedworkerscompensationproductliabilityandotherpostretirementbenefitsMember2023-01-012023-09-300000037785fmc:DiscontinuedEnvironmentalLiabilitiesMember2024-07-012024-09-300000037785fmc:DiscontinuedEnvironmentalLiabilitiesMember2023-07-012023-09-300000037785fmc:DiscontinuedEnvironmentalLiabilitiesMember2024-01-012024-09-300000037785fmc:DiscontinuedEnvironmentalLiabilitiesMember2023-01-012023-09-300000037785fmc:DiscontinuedLegalExpensesMember2024-07-012024-09-300000037785fmc:DiscontinuedLegalExpensesMember2023-07-012023-09-300000037785fmc:DiscontinuedLegalExpensesMember2024-01-012024-09-300000037785fmc:DiscontinuedLegalExpensesMember2023-01-012023-09-300000037785fmc:GrossMember2023-12-310000037785fmc:RecoveriesMember2023-12-310000037785fmc:NetMember2023-12-310000037785fmc:GrossMember2024-01-012024-09-300000037785fmc:RecoveriesMember2024-01-012024-09-300000037785fmc:NetMember2024-01-012024-09-300000037785fmc:GrossMember2024-09-300000037785fmc:RecoveriesMember2024-09-300000037785fmc:NetMember2024-09-300000037785us-gaap:OtherLiabilitiesMember2024-07-012024-09-300000037785us-gaap:OtherLiabilitiesMember2023-07-012023-09-300000037785us-gaap:OtherLiabilitiesMember2024-01-012024-09-300000037785us-gaap:OtherLiabilitiesMember2023-01-012023-09-300000037785us-gaap:OtherAssetsMember2024-07-012024-09-300000037785us-gaap:OtherAssetsMember2023-07-012023-09-300000037785us-gaap:OtherAssetsMember2024-01-012024-09-300000037785us-gaap:OtherAssetsMember2023-01-012023-09-300000037785us-gaap:SegmentContinuingOperationsMember2024-07-012024-09-300000037785us-gaap:SegmentContinuingOperationsMember2023-07-012023-09-300000037785us-gaap:SegmentContinuingOperationsMember2024-01-012024-09-300000037785us-gaap:SegmentContinuingOperationsMember2023-01-012023-09-300000037785us-gaap:SegmentDiscontinuedOperationsMember2024-07-012024-09-300000037785us-gaap:SegmentDiscontinuedOperationsMember2023-07-012023-09-300000037785us-gaap:SegmentDiscontinuedOperationsMember2024-01-012024-09-300000037785us-gaap:SegmentDiscontinuedOperationsMember2023-01-012023-09-300000037785us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000037785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000037785us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300000037785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-09-300000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000037785us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300000037785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-300000037785us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000037785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000037785us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300000037785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-09-300000037785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000037785us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300000037785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000037785us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000037785us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000037785us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000037785us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000037785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000037785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000037785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000037785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetTransitionAssetObligationMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetTransitionAssetObligationMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetTransitionAssetObligationMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetTransitionAssetObligationMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000037785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000037785us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000037785us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000037785us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000037785us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000037785us-gaap:SubsequentEventMember2024-10-172024-10-170000037785fmc:RepurchaseProgramMember2022-02-280000037785fmc:RepurchaseProgramMember2024-01-012024-09-300000037785fmc:RepurchaseProgramMember2024-09-300000037785us-gaap:PensionPlansDefinedBenefitMember2024-07-012024-09-300000037785us-gaap:PensionPlansDefinedBenefitMember2023-07-012023-09-300000037785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-07-012024-09-300000037785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-07-012023-09-300000037785us-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300000037785us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-09-300000037785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-09-300000037785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300000037785us-gaap:ForwardContractsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300000037785us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300000037785us-gaap:EnergyRelatedDerivativeMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300000037785fmc:ForeignCurrencyAndEnergyContractsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300000037785us-gaap:ForeignExchangeContractMember2024-09-300000037785us-gaap:DesignatedAsHedgingInstrumentMember2024-09-300000037785us-gaap:NondesignatedMember2024-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310000037785us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-12-310000037785us-gaap:ForeignExchangeContractMember2023-12-310000037785us-gaap:DesignatedAsHedgingInstrumentMember2023-12-310000037785us-gaap:NondesignatedMember2023-12-310000037785us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300000037785us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300000037785us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300000037785us-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300000037785us-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300000037785us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300000037785us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300000037785us-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300000037785us-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-07-012024-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-07-012023-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-01-012024-09-300000037785us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-01-012023-09-300000037785us-gaap:NondesignatedMember2024-07-012024-09-300000037785us-gaap:NondesignatedMember2023-07-012023-09-300000037785us-gaap:NondesignatedMember2024-01-012024-09-300000037785us-gaap:NondesignatedMember2023-01-012023-09-300000037785fmc:CostOfGoodsAndServicesSoldMember2023-07-012023-09-300000037785fmc:CostOfGoodsAndServicesSoldMember2023-01-012023-09-300000037785fmc:CostOfGoodsAndServicesSoldMember2024-07-012024-09-300000037785fmc:CostOfGoodsAndServicesSoldMember2024-01-012024-09-300000037785us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-300000037785us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300000037785us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-09-300000037785us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-09-300000037785us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2024-09-300000037785us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000037785us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000037785us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000037785us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2024-09-300000037785us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000037785us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000037785us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000037785us-gaap:FairValueMeasurementsRecurringMember2024-09-300000037785us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000037785us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000037785us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000037785us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2023-12-310000037785us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000037785us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000037785us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000037785us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2023-12-310000037785us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000037785us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000037785us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000037785us-gaap:FairValueMeasurementsRecurringMember2023-12-310000037785us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000037785us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000037785us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000037785us-gaap:FinancialGuaranteeMember2024-09-300000037785us-gaap:GuaranteeOfIndebtednessOfOthersMember2024-09-300000037785fmc:JacquelineScanlanMember2024-01-012024-09-300000037785fmc:JacquelineScanlanMember2024-07-012024-09-300000037785fmc:JacquelineScanlanMember2024-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________________________

 FORM 10-Q
_______________________________________________________________________
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2024
or
Transition Report Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
For the transition period from _______ to _______
Commission File Number 1-2376
__________________________________________________________________________
FMC CORPORATION
(Exact name of registrant as specified in its charter)
__________________________________________________________________________ 
Delaware 94-0479804
(State or other jurisdiction of
incorporation)
 (I.R.S. Employer
Identification No.)
2929 Walnut StreetPhiladelphiaPennsylvania19104
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: 215-299-6000
__________________________________________________________________________

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.10 per shareFMCNew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer   Accelerated filer 
Non-accelerated filer   Smaller reporting company 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes      No  

As of September 30, 2024, there were 124,835,582 of the registrant's common shares outstanding.



FMC CORPORATION
INDEX
 
 Page
No.

2


PART I - FINANCIAL INFORMATION
 
ITEM 1.    FINANCIAL STATEMENTS

FMC CORPORATION
CONSOLIDATED STATEMENTS OF INCOME (LOSS)
 
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in Millions, Except Per Share Data)(unaudited)(unaudited)
Revenue$1,065.4 $981.9 $3,021.8 $3,340.7 
Costs and Expenses
Costs of sales and services679.0 600.7 1,897.6 1,945.4 
Gross margin$386.4 $381.2 $1,124.2 $1,395.3 
Selling, general and administrative expenses159.2 171.3 487.9 562.8 
Research and development expenses69.0 80.9 205.8 247.0 
Restructuring and other charges (income)22.6 28.2 158.6 48.0 
Total costs and expenses$929.8 $881.1 $2,749.9 $2,803.2 
Income from continuing operations before non-operating pension and postretirement charges (income), interest expense, net and income taxes$135.6 $100.8 $271.9 $537.5 
Non-operating pension and postretirement charges (income)4.4 4.2 12.9 13.4 
Interest expense, net58.7 64.6 184.0 180.5 
Income (loss) from continuing operations before income taxes$72.5 $32.0 $75.0 $343.6 
Provision (benefit) for income taxes6.0 27.4 (298.9)77.7 
Income (loss) from continuing operations$66.5 $4.6 $373.9 $265.9 
Discontinued operations, net of income taxes(0.9)(8.3)(16.2)(41.3)
Net income (loss)$65.6 $(3.7)$357.7 $224.6 
Less: Net income (loss) attributable to noncontrolling interests0.6 (0.2)0.3 1.6 
Net income (loss) attributable to FMC stockholders$65.0 $(3.5)$357.4 $223.0 
Amounts attributable to FMC stockholders:
Continuing operations, net of income taxes$65.9 $4.8 $373.6 $264.3 
Discontinued operations, net of income taxes(0.9)(8.3)(16.2)(41.3)
Net income (loss) attributable to FMC stockholders$65.0 $(3.5)$357.4 $223.0 
Basic earnings (loss) per common share attributable to FMC stockholders:
Continuing operations$0.53 $0.04 $2.98 $2.11 
Discontinued operations(0.01)(0.07)(0.13)(0.33)
Net income (loss) attributable to FMC stockholders$0.52 $(0.03)$2.85 $1.78 
Diluted earnings (loss) per common share attributable to FMC stockholders:
Continuing operations$0.53 $0.04 $2.98 $2.10 
Discontinued operations(0.01)(0.07)(0.13)(0.33)
Net income (loss) attributable to FMC stockholders$0.52 $(0.03)$2.85 $1.77 
The accompanying Notes are an integral part of these consolidated financial statements.
3


FMC CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in Millions)(unaudited)(unaudited)
Net income (loss)$65.6 $(3.7)$357.7 $224.6 
Other comprehensive income (loss), net of tax:
Foreign currency adjustments:
Foreign currency translation gain (loss) arising during the period$54.1 $(40.7)$8.2 $(33.3)
Total foreign currency translation adjustments (1)
$54.1 $(40.7)$8.2 $(33.3)
Derivative instruments:
Unrealized hedging gains (losses) and other, net of tax expense (benefit) of $(5.9) and $(0.4) for the three and nine months ended September 30, 2024 and $(5.8) and $(17.6) for the three and nine months ended September 30, 2023, respectively
$(10.2)$21.6 $10.9 $(55.2)
Reclassification of deferred hedging (gains) losses and other, included in net income (loss), net of tax (expense) benefit of $2.5 and $3.2 for the three and nine months ended September 30, 2024 and $9.5 and $18.3 for the three and nine months ended September 30, 2023, respectively (2)
5.5 22.6 6.6 44.4 
Total derivative instruments, net of tax expense (benefit) of $(3.4) and $2.8 for the three and nine months ended September 30, 2024 and $3.7 and $0.7 for the three and nine months ended September 30, 2023, respectively
$(4.7)$44.2 $17.5 $(10.8)
Pension and other postretirement benefits:
Unrealized actuarial gains (losses) and prior service (costs) credits, net of tax expense (benefit) of zero for the three and nine months ended September 30, 2024 and 2023
$ $ $(0.2)$ 
Reclassification of net actuarial and other (gains) losses and amortization of prior service costs and settlement charges, included in net income (loss), net of tax (expense) benefit of $0.7 and $2.0 for the three and nine months ended September 30, 2024 and $0.7 and $2.2 for the three and nine months ended September 30, 2023, respectively (2)
2.6 2.5 7.8 8.2 
Total pension and other postretirement benefits, net of tax expense (benefit) of $0.7 and $2.0 for the three and nine months ended September 30, 2024 and $0.7 and $2.2 for the three and nine months ended September 30, 2023, respectively
$2.6 $2.5 $7.6 $8.2 
Other comprehensive income (loss), net of tax$52.0 $6.0 $33.3 $(35.9)
Comprehensive income (loss)$117.6 $2.3 $391.0 $188.7 
Less: Comprehensive income (loss) attributable to the noncontrolling interest1.7 (0.8)0.5 0.6 
Comprehensive income (loss) attributable to FMC stockholders$115.9 $3.1 $390.5 $188.1 
____________________ 
(1)Income taxes are not provided for foreign currency translation because the related investments are essentially permanent in duration.
(2)For more detail on the components of these reclassifications and the affected line item in the consolidated statements of income (loss), see Note 13.
The accompanying Notes are an integral part of these consolidated financial statements.
4


FMC CORPORATION
CONSOLIDATED BALANCE SHEETS
(in Millions, Except Share and Par Value Data)September 30, 2024December 31, 2023
ASSETS(unaudited)
Current assets
Cash and cash equivalents$416.7 $302.4 
Trade receivables, net of allowance of $41.5 in 2024 and $29.1 in 2023
2,890.5 2,703.2 
Inventories1,392.1 1,724.6 
Prepaid and other current assets616.2 398.9 
Total current assets$5,315.5 $5,129.1 
Investments25.3 19.8 
Property, plant and equipment, net869.4 892.5 
Goodwill1,517.8 1,593.6 
Other intangibles, net2,421.7 2,465.1 
Other assets including long-term receivables, net447.9 489.5 
Deferred income taxes1,621.1 1,336.6 
Total assets$12,218.7 $11,926.2 
LIABILITIES AND EQUITY
Current liabilities
Short-term debt and current portion of long-term debt$1,043.2 $934.0 
Accounts payable, trade and other802.9 602.4 
Advance payments from customers0.4 482.1 
Accrued and other liabilities739.3 684.8 
Accrued customer rebates835.1 480.9 
Guarantees of vendor financing77.9 69.6 
Accrued pension and other postretirement benefits, current6.4 6.4 
Income taxes83.2 124.4 
Total current liabilities$3,588.4 $3,384.6 
Long-term debt, less current portion3,026.8 3,023.6 
Accrued pension and other postretirement benefits, long-term23.7 24.4 
Environmental liabilities, continuing and discontinued459.1 494.7 
Deferred income taxes104.2 158.1 
Other long-term liabilities386.4 407.4 
Commitments and contingent liabilities (Note 18)
Equity
Preferred stock, no par value, authorized 5,000,000 shares; no shares issued in 2024 or 2023
$ $ 
Common stock, $0.10 par value, authorized 260,000,000 shares in 2024 and 2023; 185,983,792 shares issued in 2024 and 2023
18.6 18.6 
Capital in excess of par value of common stock960.9 935.6 
Retained earnings6,726.4 6,587.1 
Accumulated other comprehensive income (loss)(373.4)(406.5)
Treasury stock, common, at cost - 2024: 61,148,210 shares, 2023: 61,223,032 shares
(2,724.7)(2,723.9)
Total FMC stockholders’ equity$4,607.8 $4,410.9 
Noncontrolling interests22.3 22.5 
Total equity$4,630.1 $4,433.4 
Total liabilities and equity$12,218.7 $11,926.2 
The accompanying Notes are an integral part of these consolidated financial statements.
5


FMC CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Nine Months Ended September 30,
20242023
 (in Millions)
(unaudited)
Cash provided (required) by operating activities of continuing operations:
Net income (loss)$357.7 $224.6 
Discontinued operations, net of income taxes16.2 41.3 
Income (loss) from continuing operations$373.9 $265.9 
Adjustments from income from continuing operations to cash provided (required) by operating activities of continuing operations:
Depreciation and amortization$133.2 $138.4 
Restructuring and other charges (income)158.6 48.0 
Deferred income taxes(376.4)2.4 
Pension and other postretirement benefits14.5 15.5 
Share-based compensation18.1 19.8 
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:
Trade receivables, net(269.9)312.4 
Guarantees of vendor financing8.3 (46.4)
Advance payments from customers(481.8)(678.2)
Accrued customer rebates363.5 348.3 
Inventories301.3 (363.2)
Accounts payable, trade and other206.0 (562.0)
Income taxes(71.9)(96.9)
Pension and other postretirement benefit contributions(2.3)(1.4)
Environmental spending, continuing, net of recoveries(22.3)(22.7)
Restructuring and other spending (1)
(102.5)(17.2)
Change in other operating assets and liabilities, net (2)
58.5 19.1 
Cash provided (required) by operating activities of continuing operations$308.8 $(618.2)
Cash provided (required) by operating activities of discontinued operations:
Environmental spending, discontinued, net of recoveries$(32.6)$(34.4)
Other discontinued spending(3)
(4.6)(26.6)
Cash provided (required) by operating activities of discontinued operations$(37.2)$(61.0)
____________________ 
(1)In addition to cash payments shown in our roll forward of restructuring reserves in Note 8 to our consolidated financial statements included within this Form 10-Q, the restructuring and other spending amount above for the nine months ended September 30, 2024 includes spending of $4.6 million in divestiture transaction costs and $5.9 million related to the Furadan® asset retirement obligations. The nine months ended September 30, 2023 includes spending of $3.4 million related to the Furadan® asset retirement obligations. For additional detail on restructuring and other charges activities, see Note 8.
(2)Changes in all periods primarily represent timing of payments associated with all other operating assets and liabilities.
(3)Discontinued operations for the nine months ended September 30, 2024 includes cash proceeds, net of fees of $18.0 million received as the result of an insurance settlement for retained legal reserves.
The accompanying Notes are an integral part of these consolidated financial statements.
(continued)
6


FMC CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
 
Nine Months Ended September 30,
20242023
 (in Millions)(unaudited)
Cash provided (required) by investing activities of continuing operations:
Capital expenditures$(46.3)$(108.8)
Acquisitions, including cost and equity method, net (4)
(4.4)(16.0)
Proceeds from land disposition (5)
 5.8 
Other investing activities(5.2)(7.8)
Cash provided (required) by investing activities of continuing operations$(55.9)$(126.8)
Cash provided (required) by financing activities of continuing operations:
Increase (decrease) in short-term debt$119.1 $158.4 
Repayments of long-term debt (800.0)
Proceeds from borrowings of long-term debt 1,498.6 
Financing fees and interest rate swap settlements (0.4)
Distributions to noncontrolling interests(0.7)(0.6)
Issuances of common stock, net0.2 5.2 
Dividends paid (6)
(217.9)(217.9)
Repurchases of common stock under publicly announced program (75.0)
Other repurchases of common stock(2.2)(6.2)
Cash provided (required) by financing activities of continuing operations$(101.5)$562.1 
Effect of exchange rate changes on cash and cash equivalents0.1 (4.3)
Increase (decrease) in cash and cash equivalents$114.3 $(248.2)
Cash and cash equivalents, beginning of period$302.4 $572.0 
Cash and cash equivalents, end of period$416.7 $323.8 
____________________ 
(4)The acquisitions, including cost and equity method, net amount in 2023 includes the $11.9 million payment related to the in-process research and development assets acquired during the third quarter.
(5)During the nine months ended September 30, 2023, we received the final payment of $5.8 million related to a land transfer agreement with the Shanghai Municipal People's Government, which was executed in December 2022.
(6)See Note 13 regarding the quarterly cash dividend.    
Supplemental disclosure of cash flow information: Cash paid for interest, net of capitalized interest was $149.6 million and $135.0 million, and income taxes paid, net of refunds were $137.1 million and $143.2 million for the nine months ended September 30, 2024 and 2023, respectively. Non-cash additions to property, plant and equipment and other assets were $12.7 million and $20.2 million for the nine months ended September 30, 2024 and 2023, respectively. Non-cash investing activities include a $11.4 million investment representing the deferred purchase price in a trade receivables securitization program for the nine months ended September 30, 2024.
The accompanying Notes are an integral part of these consolidated financial statements.
7


FMC CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(UNAUDITED)
 FMC Stockholders’ Equity  
(in Millions, Except Per Share Data)
Common
Stock,
$0.10 Par
Value
Capital In Excess of ParRetained
Earnings
Accumulated Other Comprehensive Income (Loss)Treasury
Stock
Non-controlling
Interest
Total
Equity
Balance at December 31, 2023$18.6 $935.6 $6,587.1 $(406.5)$(2,723.9)$22.5 $4,433.4 
Net income (loss)— — (2.7)— — (0.4)(3.1)
Stock compensation plans— 6.8 — — 1.4 — 8.2 
Shares for benefit plan trust— — — — (1.7)— (1.7)
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1)
— — — 2.5 — — 2.5 
Net hedging gains (losses) and other, net of income tax (1)
— — — (14.5)— — (14.5)
Foreign currency translation adjustments (1)
— — — (36.0)— (0.7)(36.7)
Dividends ($0.58 per share)
— — (72.6)— — — (72.6)
Repurchases of common stock— — — — (0.5)— (0.5)
Balance at March 31, 2024$18.6 $942.4 $6,511.8 $(454.5)$(2,724.7)$21.4 $4,315.0 
Net income (loss)— — 295.1 — — 0.1 295.2 
Stock compensation plans— 13.2 — — — — 13.2 
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1)
— — — 2.5 — — 2.5 
Net hedging gains (losses) and other, net of income tax (1)
— — — 36.7 — — 36.7 
Foreign currency translation adjustments (1)
— — — (9.0)— (0.2)(9.2)
Dividends ($0.58 per share)
— — (72.7)— —  (72.7)
Balance at June 30, 2024$18.6 $955.6 $6,734.2 $(424.3)$(2,724.7)$21.3 $4,580.7 
Net income (loss)— — 65.0 — — 0.6 65.6 
Stock compensation plans— 5.3 — —  — 5.3 
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1)
— — — 2.6 — — 2.6 
Net hedging gains (losses) and other, net of income tax (1)
— — — (4.7)— — (4.7)
Foreign currency translation adjustments (1)
— — — 53.0 — 1.1 54.1 
Dividends ($0.58 per share)
— — (72.8)— — — (72.8)
Distributions to noncontrolling interests— — — — — (0.7)(0.7)
Balance at September 30, 2024$18.6 $960.9 $6,726.4 $(373.4)$(2,724.7)$22.3 $4,630.1 
____________________
(1)See consolidated statements of comprehensive income (loss).
The accompanying Notes are an integral part of these consolidated financial statements.
(continued)
8


 FMC Stockholders’ Equity  
(in Millions, Except Per Share Data)
Common
Stock,
$0.10 Par
Value
Capital In Excess of ParRetained
Earnings
Accumulated Other Comprehensive Income (Loss)Treasury
Stock
Non-controlling
Interest
Total
Equity
Balance at December 31, 2022$18.6 $909.2 $5,555.9 $(459.6)$(2,646.2)$23.0 $3,400.9 
Net income (loss)— — 196.0 — — (0.1)195.9 
Stock compensation plans— 7.2 — — 2.4 — 9.6 
Shares for benefit plan trust— — — — (0.1)— (0.1)
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1)
— — — 2.9 — — 2.9 
Net hedging gains (losses) and other, net of income tax (1)
— — — (31.3)— — (31.3)
Foreign currency translation adjustments (1)
— — — 19.2 — 0.9 20.1 
Dividends ($0.58 per share)
— — (72.7)— — — (72.7)
Repurchases of common stock— — — — (30.8)— (30.8)
Balance at March 31, 2023$18.6 $916.4 $5,679.2 $(468.8)$(2,674.7)$23.8 $3,494.5 
Net income (loss)— — 30.5 — — 1.9 32.4 
Stock compensation plans— 6.0 — — 2.4 — 8.4 
Shares for benefit plan trust— — — — (0.7)— (0.7)
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1)
— — — 2.8 — — 2.8 
Net hedging gains (losses) and other, net of income tax (1)
— — — (23.7)— — (23.7)
Foreign currency translation adjustments (1)
— — — (11.4)— (1.3)(12.7)
Dividends ($0.58 per share)
— — (72.5)— — — (72.5)
Repurchases of common stock— — — — (51.1)— (51.1)
Balance at June 30, 2023$18.6 $922.4 $5,637.2 $(501.1)$(2,724.1)$24.4 $3,377.4 
Net income (loss)— — (3.5)— — (0.2)(3.7)
Stock compensation plans— 7.1 — — 0.4 — 7.5 
Shares for benefit plan trust— — — — (0.1)— (0.1)
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1)
— — — 2.5 — — 2.5 
Net hedging gains (losses) and other, net of income tax (1)
— — — 44.2 — — 44.2 
Foreign currency translation adjustments (1)
— — — (40.1)— (0.6)(40.7)
Dividends ($0.58 per share)
— — (72.6)— — — (72.6)
Balance at September 30, 2023$18.6 $929.5 $5,561.1 $(494.5)$(2,723.8)$23.6 $3,314.5 
____________________
(1)See consolidated statements of comprehensive income (loss).
The accompanying Notes are an integral part of these consolidated financial statements.

9


FMC CORPORATION
Notes to Consolidated Financial Statements (unaudited)
Note 1: Financial Information and Accounting Policies
In our opinion, the consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") applicable to interim period financial statements and reflect all adjustments necessary for a fair statement of results of operations for the three and nine months ended September 30, 2024 and 2023, cash flows for the nine months ended September 30, 2024 and 2023, changes in equity for the three and nine months ended September 30, 2024 and 2023, and our financial positions as of September 30, 2024 and December 31, 2023. All such adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the Notes. The results of operations for the three and nine months ended September 30, 2024 and 2023 are not necessarily indicative of the results of operations for the full year. The consolidated balance sheet as of September 30, 2024, and the related consolidated statements of income (loss) and consolidated statements of comprehensive income (loss) for the three and nine months ended September 30, 2024 and 2023, consolidated statements of cash flows for the nine months ended September 30, 2024 and 2023, and consolidated statements of changes in equity for the three and nine months ended September 30, 2024 and 2023 have been reviewed by our independent registered public accountants. The review is described more fully in their report included herein. The consolidated balance sheet as of December 31, 2023 was audited by our independent registered public accountants. Our accounting policies are set forth in detail in Note 1 to the consolidated financial statements included with our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") for the year ended December 31, 2023 (the "2023 Form 10-K").
Assets Held for Sale
In the second quarter of 2024, our Global Specialty Solutions ("GSS") business met the criteria to be presented as assets held for sale. Additionally, on July 11, 2024, we signed a definitive agreement to sell this business to Environmental Science US, LLC d/b/a Envu for a purchase price of $350 million, subject to closing working capital adjustments. The fair value, less costs to sell, is expected to exceed the preliminary carrying value. As of September 30, 2024, assets of approximately $159 million are presented within the Prepaid and other current assets line item on the Consolidated Balance Sheet and consist primarily of $50 million in trade receivables, $32 million in inventories, and $77 million representing an allocated portion of goodwill. Accrued rebates of $7 million related to the GSS business are presented within the Accrued and other liabilities line item on the Consolidated Balance Sheet. We continue to expect to complete the sale by the end of 2024. Certain assets, which are not expected to be material, are anticipated to be transferred to Envu at a later date due to various local timing constraints; however, we will receive consideration for these assets at closing of the sale and no additional consideration will be received at the date of transfer. The GSS business does not qualify for discontinued operations and, therefore, its results are included in income (loss) from continuing operations for all periods presented.
Note 2: Recently Issued and Adopted Accounting Pronouncements and Regulatory Items
New accounting guidance and regulatory items
On March 6, 2024, the SEC adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors, which will require registrants to provide certain climate-related information in their registration statements and periodic reports. The required disclosures will include, but are not limited to, specific disclosures about climate-related risks and their actual or likely material impacts on the registrant’s business, strategy, and outlook; the governance of climate-related risks and relevant risk management processes; Scope 1 and 2 greenhouse gas (GHG) emissions, if material or included in announced emission targets; certain climate-related financial statement metrics and related disclosures in a note to the audited financial statements; and information about climate-related targets and goals. The rules are effective on a rolling basis for various fiscal years, beginning for the Company with annual reports for the year ending December 31, 2025. However, in response to various legal challenges, the SEC voluntarily stayed the rules on April 4, 2024, which may impact the ultimate effective date of the rules. We are currently gathering the required data and information to comply with the rules by the current effective date and we will continue to monitor any developments on these rules and expected timing for compliance.
10


FMC CORPORATION
Notes to Consolidated Financial Statements (unaudited) — (Continued)
On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Changes to the Disclosure Requirements for Income Taxes, to improve the transparency and decision usefulness of income tax disclosures. The standard requires companies to disclose a tabular effective rate reconciliation with certain reconciling items broken out by nature and/or jurisdiction as well as more robust disclosures of income taxes paid, specifically broken out between federal, state and foreign. The standard can be applied prospectively or retrospectively and early adoption is permitted. The ASU is effective for FMC beginning with the Form 10-K for the year ended December 31, 2025. We are currently evaluating the impacts this standard will have on our income tax disclosures.
On November 27, 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, to improve the disclosures about a public entity's reportable segments and expenses. The standard requires disclosure of the chief operating decision maker's (the "CODM") title and position and allows for disclosure of multiple measures of segment profit and loss reviewed by the CODM. Companies with multiple reportable segments as well as companies with a single reportable segment are required to adopt the standard and it should be applied retrospectively to all periods presented. The ASU is effective for FMC beginning with the Form 10-K for the year ended December 31, 2024. Early adoption is permitted. Because we operate as a single reportable segment, most of the required information is currently available in our quarterly or annual filings. We expect to update our disclosures in our Form 10-K for the year ended December 31, 2024 to present the required information, which may result in new disclosures as well as updates to the geography of certain disclosures.
Recently adopted accounting guidance
On December 20, 2021, the Organization for Economic Co-operation and Development (the "OECD") released Pillar Two Model Rules defining the global minimum tax, which calls for the taxation of large corporations at a minimum rate of 15 percent. The OECD continues to release additional guidance on the two-pillar framework. Pillar Two legislation has been enacted in certain jurisdictions in which the Company operates, which became effective for the Company’s financial year beginning January 1, 2024. We have performed an assessment of our potential exposure to Pillar Two income taxes for these jurisdictions, which was not material. We are continuing to evaluate this estimate as well as the potential impact on future periods of the Pillar Two Framework, pending legislative adoption by individual countries.
In September 2022, the FASB issued ASU No. 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. In accordance with the new disclosure requirements, which we have adopted beginning January 1, 2023, we have included information regarding our key program terms and the amount outstanding that remains unpaid at period end as further described below. We will adopt the roll forward disclosure requirement when it becomes effective beginning with the Form 10-K for the year ended December 31, 2024.
We work with suppliers to optimize payment terms and conditions on accounts payable to improve working capital and cash flows. We offer to a select group of suppliers a voluntary Supply Chain Finance (“SCF”) program with a global financial institution. The suppliers, at their sole discretion, may sell their receivables to the financial institution based on terms negotiated between them. Our obligations to our suppliers are not impacted by our suppliers’ decisions to sell under these arrangements. Obligations outstanding under this program are recorded within "Accounts payable, trade and other" in our consolidated balance sheets and the associated payments are included in operating activities within our consolidated statements of cash flows.
Our payment terms with our suppliers are consistent, regardless of whether a supplier participates in the program. We deem these terms to be commercially reasonable and consistent with the range of industry standards within their respective regions. Under the terms of the agreement, we do not pledge assets as security or make any other forms of guarantees.
FMC's outstanding obligations confirmed as valid under the SCF was $226.0 million and $71.9 million as of September 30, 2024 and December 31, 2023, respectively.
Note 3: Revenue Recognition
Disaggregation of revenue
We disaggregate revenue from contracts with customers by geographical areas and major product categories. We have three major agricultural product categories: insecticides, herbicides, and fungicides. Plant health, which includes biological products, is also included in the below table. The disaggregated revenue tables are shown below for the three and nine months ended September 30, 2024 and 2023.
11


FMC CORPORATION
Notes to Consolidated Financial Statements (unaudited) — (Continued)
The following table provides information about disaggregated revenue by major geographical region:
Three Months Ended September 30,Nine Months Ended September 30,
(in Millions)2024202320242023
North America$235.5 $159.6 $833.4 $929.4 
Latin America504.1 466.1 999.3 968.4 
Europe, Middle East & Africa (EMEA)139.3 149.0 647.3 739.6 
Asia186.5 207.2 541.8 703.3 
Total Revenue$1,065.4 $981.9 $3,021.8 $3,340.7 
The following table provides information about disaggregated revenue by product category:
Three Months Ended September 30,Nine Months Ended September 30,
(in Millions)2024202320242023
Insecticides$647.9 $582.4 $1,718.3 $1,988.0 
Herbicides275.6 268.0 907.1 936.3 
Fungicides84.8 55.5 229.7 228.8 
Plant Health47.3 42.6 135.6 138.3 
Other9.8 33.4 31.1 49.3 
Total Revenue$1,065.4 $981.9 $3,021.8 $3,340.7 
We earn revenue from the sale of a wide range of products to a diversified base of customers around the world. We develop, market and sell all three major classes of crop protection chemicals (insecticides, herbicides and fungicides) as well as biologicals, crop nutrition, and seed treatment products, which we group as plant health. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. The majority of our product lines consist of insecticides and herbicides, with a smaller portfolio of fungicides mainly used in high value crop segments. We are investing in plant health which includes our growing biological products. Our insecticides are used to control a wide spectrum of pests, while our herbicide portfolio primarily targets a large variety of difficult-to-control weeds. Products in the other category include various agricultural products such as smaller classes of pesticides, growth promoters, and other miscellaneous revenue sources.
For additional detail on revenue recognition policies and procedures, see Note 3 to our consolidated financial statements included within our 2023 Form 10-K.
Contract Asset and Contract Liability Balances
We satisfy our obligations by transferring goods and services in exchange for consideration from customers. The timing of performance sometimes differs from the timing the associated consideration is received from the customer, thus resulting in the recognition of a contract asset or contract liability. We recognize a contract liability if the customer's payment of consideration is received prior to completion of our related performance obligation.
12


FMC CORPORATION
Notes to Consolidated Financial Statements (unaudited) — (Continued)
The following table presents the opening and closing balances of our receivables, net of allowances and contract liabilities from contracts with customers:
(in Millions)Balance as of September 30, 2024Balance as of December 31, 2023Increase (Decrease)
Receivables from contracts with customers, net of allowances (1)
$2,919.6 $2,722.7 $196.9 
Contract liabilities: Advance Payments from customers (2)
0.4 482.1 (481.7)
____________________ 
(1)Amount includes $2,890.5 million of trade receivables and $29.1 million of net long-term customer receivables as of September 30, 2024. See Note 5 for more information.
(2)The amount of revenue recognized in the nine months ended September 30, 2024 that was included in the opening contract liability balance is $481.7 million.
The balance of receivables from contracts with customers listed in the table above include both current trade receivables and long-term receivables, net of allowance for doubtful accounts. The allowance for receivables represents our best estimate of the probable losses associated with potential customer defaults. We determine the allowance based on historical experience, current collection trends, and external business factors such as economic factors, including regional bankruptcy rates, and political factors. The change in allowance for doubtful accounts for both current trade receivables and long-term receivables is representative of the impairment of receivables as of September 30, 2024. Refer to Note 5 for further information.
We periodically enter into prepayment arrangements with customers and receive advance payments for product to be delivered in future periods. We recognize these prepayments as a liability under "Advance payments from customers" on the consolidated balance sheets when they are received. Revenue associated with advance payments is recognized as shipments are made and transfer of control to the customer takes place.
Note 4: Goodwill and Intangible Assets
The changes in the carrying amount of goodwill are presented in the table below:
(in Millions)Total
Balance, December 31, 2023$1,593.6 
GSS allocation to held for sale (See Note 1.)
(77.0)
Foreign currency adjustments
1.2 
Balance, September 30, 2024$1,517.8 
We perform our goodwill and indefinite-lived intangible asset impairment tests at least annually. Our fiscal year 2024 annual goodwill and indefinite-lived intangible asset impairment test was performed during the three months ended September 30, 2024. We determined no goodwill impairment existed and that the fair value was in excess of the carrying value. Additionally, no indefinite-lived asset impairment existed and the estimated fair values also exceeded the carrying value for each of our indefinite-lived intangible assets.
13


FMC CORPORATION
Notes to Consolidated Financial Statements (unaudited) — (Continued)
Our intangible assets, other than goodwill, consist of the following:
September 30, 2024December 31, 2023
(in Millions)GrossAccumulated AmortizationNetGrossAccumulated AmortizationNet
Intangible assets subject to amortization (finite-lived)
Customer relationships$1,139.4 $(455.4)$684.0 $1,136.7 $(414.2)$722.5 
Patents1.7 (1.7) 1.8 (1.6)0.2 
Brands (1)
49.5 (19.0)30.5 49.3 (12.9)36.4 
Purchased and licensed technologies131.9 (48.5)83.4 131.1 (46.2)84.9 
Other intangibles2.4 (1.8)0.6 2.3 (1.8)0.5 
$1,324.9 $(526.4)$798.5 $1,321.2 $(476.7)$844.5 
Intangible assets not subject to amortization (indefinite-lived)
Crop Protection Brands (2)
$1,259.0 $1,259.0 $1,259.0 $1,259.0 
Brands (1)
352.8 352.8 350.3 350.3 
In-process research & development11.4 11.4 11.3 11.3 
$1,623.2 $1,623.2 $1,620.6 $1,620.6 
Total intangible assets$2,948.1 $(526.4)$2,421.7 $2,941.8 $(476.7)$2,465.1 
____________________ 
(1)Represents trademarks, trade names and know-how.
(2)Represents proprietary brand portfolios, consisting of trademarks, trade names and know-how, of our crop protection brands.

Three Months Ended September 30,Nine Months Ended September 30,
(in Millions)2024202320242023
Amortization expense$16.4 $16.2 $49.2 $48.3 
The full year estimated pre-tax amortization expense for the year ended December 31, 2024 and each of the succeeding five years is approximately $64 million, $68 million, $69 million, $69 million, $70 million, and $69 million, respectively.
Note 5: Receivables
The following table displays a roll forward of the allowance for doubtful trade receivables.
(in Millions)
Balance, December 31, 2022$33.9 
Additions - charged to expense
4.7 
Transfer from (to) allowance for credit losses (see below)(1.5)
Net recoveries, write-offs and other
(8.0)
Balance, December 31, 2023$29.1 
Additions - charged to expense
13.4 
Transfer from (to) allowance for credit losses (see below)0.1 
Net recoveries, write-offs and other(1.1)
Balance, September 30, 2024$41.5 
14


FMC CORPORATION
Notes to Consolidated Financial Statements (unaudited) — (Continued)
We have non-current receivables that represent long-term customer receivable balances related to past due accounts which are not expected to be collected within the current year. The net long-term customer receivables were $29.1 million as of September 30, 2024. These long-term customer receivable balances and the corresponding allowance are included in "Other assets including long-term receivables, net" on the consolidated balance sheets.
A portion of these long-term receivables have payment contracts. We have no reason to believe payments will not be made based upon the credit quality of these customers. Additionally, we also hold significant collateral against these customers including rights to property or other assets as a form of credit guarantee. If the customer does not pay or gives indication that they will not pay, these guarantees allow us to start legal action to block the sale of the customer’s harvest. On an ongoing basis, we continue to evaluate the credit quality of our non-current receivables using aging of receivables, collection experience and write-offs, as well as evaluating existing economic conditions, to determine if an additional allowance is necessary.
The following table displays a roll forward of the allowance for credit losses related to long-term customer receivables:
(in Millions)
Balance, December 31, 2022$44.5 
Additions - charged (credited) to expense
1.6 
Transfer from (to) allowance for doubtful accounts (see above)1.5 
Foreign currency adjustments0.8 
Net recoveries, write-offs and other(21.3)
Balance, December 31, 2023$27.1 
Additions - charged (credited) to expense
1.2 
Transfer from (to) allowance for doubtful accounts (see above)(0.1)
Foreign currency adjustments(1.9)
Balance, September 30, 2024$26.3 
Receivables Securitization Facility:
FMC participates in certain trade receivables securitization programs, primarily impacting our Brazilian operations. On a revolving basis, FMC may sell certain trade receivables into the facilities in exchange for cash. A portion of the total receivables sold are deferred as an asset on our consolidated balance sheets representing FMC’s beneficial interest in the securitization funds.
In all instances, the transferred financial assets are sold on a non-recourse basis and have met the true sale criteria under ASC Topic 860. FMC has surrendered control of the receivables and as a result they are no longer recognized on the consolidated balance sheets. FMC may be engaged to serve as a special servicer for any delinquent receivables. In that capacity, we are entitled to market rate compensation for those services.
Cash receipts from the sale of trade receivables under the securitization arrangements, received at the time of sale, are classified as cash flows from operating activities.
There were $128.4 million in receivables sold under the securitization programs during the nine months ended September 30, 2024. A $11.9 million charge associated with the transfer of these financial assets is included as a component within selling, general and administrative expense during the nine months ended September 30, 2024. There were $97.3 million in receivables sold under the securitization program during the nine months ended September 30, 2023.
As part of funding our interest for all outstanding arrangements under the securitization programs, approximately $30.7 million of the sales have been retained by the investment fund and will be returned to FMC, including interest, at the maturity of the securitization. This asset is recorded within "Other assets including long-term receivables, net" on the consolidated balance sheets.
15


FMC CORPORATION
Notes to Consolidated Financial Statements (unaudited) — (Continued)
Other Receivable Factoring:
In addition to the above, we may sell trade receivables on a non-recourse basis to third-party financial institutions. These sales are normally driven by specific market conditions, including, but not limited to, foreign exchange environments, customer credit management, as well as other factors where the receivables originate.
We account for these transactions as true sales and as a result they are no longer recognized on the consolidated balance sheets because the agreements transfer effective control and risk related to the receivables to the buyers. The net cash proceeds received are presented within cash provided by operating activities within our consolidated statements of cash flows. The cost of factoring these accounts receivables is recorded within "Selling, general and administrative expenses" on the consolidated statements of income (loss) and has been inconsequential during each reporting period. Non-recourse factoring during the nine months ended September 30, 2024 and 2023 was $71.3 million and $155.0 million, respectively.
Note 6: Inventories

Inventories consisted of the following:
 (in Millions)September 30, 2024December 31, 2023
Finished goods$472.6 $643.8 
Work in process701.3 732.2 
Raw materials, supplies and other218.2 348.6 
Net inventories$1,392.1 $1,724.6 

Note 7: Property, Plant and Equipment
Property, plant and equipment consisted of the following:
(in Millions)September 30, 2024December 31, 2023
Property, plant and equipment$1,616.3 $1,559.8 
Accumulated depreciation(746.9)(667.3)
Property, plant and equipment, net$869.4 $892.5 

Note 8: Restructuring and Other Charges (Income)
Our restructuring and other charges (income) are comprised of restructuring, asset disposals and other charges (income) as noted below.
 Three Months Ended September 30,Nine Months Ended September 30,
(in Millions)2024202320242023
Restructuring charges$15.7 $2.9 $133.2 $2.9 
Other charges (income), net6.9 25.3 25.4 45.1 
Total restructuring and other charges (income)$22.6 $28.2 $158.6 $48.0 
16


FMC CORPORATION
Notes to Consolidated Financial Statements (unaudited) — (Continued)
Restructuring charges
For detail on restructuring activities that commenced prior to 2024, see Note 8 to our consolidated financial statements included within our 2023 Form 10-K.
Restructuring Charges
(in Millions)
Severance and Employee Benefits
Other Charges (Income) (1)
Asset Disposal Charges (Income) (2)
Total
Project Focus$7.0 $5.4 $6.2 $18.6 
Other items (2.9) (2.9)
Three Months Ended September 30, 2024$7.0 $2.5 $6.2 $15.7 
Other items2.5 0.4  2.9 
Three Months Ended September 30, 2023$2.5 $0.4 $ $2.9 
Project Focus$44.5 $24.1 $67.7 $136.3 
Other items (3.1) (3.1)
Nine Months Ended September 30, 2024$44.5 $21.0 $67.7 $133.2 
DuPont Crop restructuring$ $(8.1)